🇺🇸 Subcutaneous glargine insulin in United States

Subcutaneous glargine insulin (Subcutaneous glargine insulin) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Subcutaneous glargine insulin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Subcutaneous glargine insulin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Subcutaneous glargine insulin in United States?

Fundación Pública Andaluza Progreso y Salud is the originator. The local marketing authorisation holder may differ — check the official source linked above.